2024 Q1 Form 10-Q Financial Statement

#000088218424000014 Filed on January 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $9.107B $7.726B
YoY Change 14.23% 6.45%
Cost Of Revenue $6.767B $5.720B
YoY Change 12.85% 8.1%
Gross Profit $2.340B $2.006B
YoY Change 18.4% 2.02%
Gross Profit Margin 25.7% 25.97%
Selling, General & Admin $879.2M $835.0M
YoY Change 13.65% 13.3%
% of Gross Profit 37.57% 41.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.10M $20.00M
YoY Change -20.97% 1.01%
% of Gross Profit 0.9% 1.0%
Operating Expenses $789.6M $835.0M
YoY Change 7.96% 13.3%
Operating Profit $1.551B $1.171B
YoY Change 24.53% -4.74%
Interest Expense -$13.40M -$14.90M
YoY Change 38.14% 83.95%
% of Operating Profit -0.86% -1.27%
Other Income/Expense, Net $76.20M $76.30M
YoY Change 80.57% 102.39%
Pretax Income $1.529B $1.248B
YoY Change 22.74% -1.55%
Income Tax $344.8M $291.8M
% Of Pretax Income 22.56% 23.39%
Net Earnings $1.172B $947.4M
YoY Change 24.4% -1.18%
Net Earnings / Revenue 12.87% 12.26%
Basic Earnings Per Share $3.54 $2.84
Diluted Earnings Per Share $3.52 $2.82
COMMON SHARES
Basic Shares Outstanding 331.8M shares 333.2M shares
Diluted Shares Outstanding 333.3M shares 335.7M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.063B $3.323B
YoY Change 0.39% 28.26%
Cash & Equivalents $3.063B $3.323B
Short-Term Investments
Other Short-Term Assets $98.10M $100.8M
YoY Change 18.05% 14.42%
Inventory $24.84B $24.05B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $28.33B $27.77B
YoY Change 10.55% 9.15%
LONG-TERM ASSETS
Property, Plant & Equipment $526.4M $475.5M
YoY Change 3.3% -5.22%
Goodwill $163.5M $163.5M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $196.8M $197.1M
YoY Change 44.92% 23.73%
Total Long-Term Assets $6.073B $5.612B
YoY Change 9.47% 16.38%
TOTAL ASSETS
Total Short-Term Assets $28.33B $27.77B
Total Long-Term Assets $6.073B $5.612B
Total Assets $34.40B $33.38B
YoY Change 10.35% 10.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.387B $1.260B
YoY Change 10.8% 4.59%
Accrued Expenses $2.434B $2.295B
YoY Change -14.01% 9.44%
Deferred Revenue
YoY Change
Short-Term Debt $1.884B $1.280B
YoY Change 21.17% 5.42%
Long-Term Debt Due $221.5M $214.6M
YoY Change -62.49% -75.65%
Total Short-Term Liabilities $6.137B $5.689B
YoY Change 50.35% -4.66%
LONG-TERM LIABILITIES
Long-Term Debt $3.832B $3.796B
YoY Change -35.77% 5.59%
Other Long-Term Liabilities $132.0M $292.6M
YoY Change -16.61% 95.46%
Total Long-Term Liabilities $3.964B $4.089B
YoY Change -33.56% 9.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.137B $5.689B
Total Long-Term Liabilities $3.964B $4.089B
Total Liabilities $10.58B $9.778B
YoY Change 1.19% 0.68%
SHAREHOLDERS EQUITY
Retained Earnings $25.51B $24.44B
YoY Change 21.97% 21.83%
Common Stock $3.436B $3.444B
YoY Change 2.19% 2.63%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.130B $4.728B
YoY Change 43.96% 45.01%
Treasury Stock Shares
Shareholders Equity $23.82B $23.15B
YoY Change
Total Liabilities & Shareholders Equity $34.40B $33.38B
YoY Change 10.35% 10.3%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $1.172B $947.4M
YoY Change 24.4% -1.18%
Depreciation, Depletion And Amortization $21.10M $20.00M
YoY Change -20.97% 1.01%
Cash From Operating Activities -$316.7M -$153.4M
YoY Change -149.14% -118.5%
INVESTING ACTIVITIES
Capital Expenditures $23.70M $47.60M
YoY Change -25.24% 0.21%
Acquisitions $1.000M
YoY Change -98.97%
Other Investing Activities -$3.000M $600.0K
YoY Change -50.0% -135.29%
Cash From Investing Activities -$26.70M -$39.30M
YoY Change -29.18% -72.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 92.20M -$362.8M
YoY Change -163.72% -43.89%
NET CHANGE
Cash From Operating Activities -316.7M -$153.4M
Cash From Investing Activities -26.70M -$39.30M
Cash From Financing Activities 92.20M -$362.8M
Net Change In Cash -251.2M -$555.5M
YoY Change -154.36% -1502.78%
FREE CASH FLOW
Cash From Operating Activities -$316.7M -$153.4M
Capital Expenditures $23.70M $47.60M
Free Cash Flow -$340.4M -$201.0M
YoY Change -155.55% -125.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
5719800000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
5291300000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
835000000.0 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
737000000.0 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76300000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37700000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1247500000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1267200000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
291800000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
298900000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
955700000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
968300000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8300000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9600000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
947400000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
958700000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.79
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
333300000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344200000 shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.82
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.76
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335700000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
346900000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23137900000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
955700000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1600000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3100000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37500000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40900000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
99900000 usd
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
398300000 usd
CY2023Q4 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23603500000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19785600000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
968300000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2600000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2900000 usd
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25700000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22900000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
86100000 usd
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
118100000 usd
CY2022Q4 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20552400000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
955700000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
968300000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000000.0 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19800000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
40900000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
22900000 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-11300000 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-3200000 usd
CY2023Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
6100000 usd
CY2022Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
27500000 usd
CY2023Q4 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
466400000 usd
CY2022Q4 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-320700000 usd
CY2023Q4 us-gaap Increase Decrease In Inventory For Long Term Contracts Or Programs
IncreaseDecreaseInInventoryForLongTermContractsOrPrograms
937800000 usd
CY2022Q4 us-gaap Increase Decrease In Inventory For Long Term Contracts Or Programs
IncreaseDecreaseInInventoryForLongTermContractsOrPrograms
637500000 usd
CY2023Q4 dhi Increase Decrease In Rental Properties
IncreaseDecreaseInRentalProperties
256500000 usd
CY2022Q4 dhi Increase Decrease In Rental Properties
IncreaseDecreaseInRentalProperties
357000000.0 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
130000000.0 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-330200000 usd
CY2023Q4 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-475800000 usd
CY2022Q4 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-603300000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
127500000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-472300000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-153400000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
829100000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47600000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47500000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
9900000 usd
CY2022Q4 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 usd
CY2023Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1000000.0 usd
CY2022Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
97100000 usd
CY2023Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
600000 usd
CY2022Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1700000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39300000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-142900000 usd
CY2023Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
720000000.0 usd
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
300000000.0 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
170000000.0 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
300000000.0 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-389900000 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-404400000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1600000 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5500000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37500000 usd
CY2023Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
99900000 usd
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
86100000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
376900000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
118100000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-10200000 usd
CY2022Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17800000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-362800000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-646600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-555500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39600000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3900100000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572900000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3344600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2612500000 usd
CY2023Q4 us-gaap Notes Issued1
NotesIssued1
21900000 usd
CY2022Q4 us-gaap Notes Issued1
NotesIssued1
31200000 usd
CY2023Q4 us-gaap Stock Issued1
StockIssued1
66500000 usd
CY2022Q4 us-gaap Stock Issued1
StockIssued1
46900000 usd
CY2023Q4 dhi Repurchase Of Common Stock Not Settled
RepurchaseOfCommonStockNotSettled
18300000 usd
CY2022Q4 dhi Repurchase Of Common Stock Not Settled
RepurchaseOfCommonStockNotSettled
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3323400000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21200000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9467700000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
11497100000 usd
CY2023Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
134500000 usd
CY2023Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
3500000 usd
CY2023Q4 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
2947500000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
24050300000 usd
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2044100000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
175900000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
475500000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
3127700000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
163500000 usd
CY2023Q4 us-gaap Assets
Assets
33381600000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1260300000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3227400000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
5290400000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9778100000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3873600000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
26500000 usd
CY2023Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9001400000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
10621900000 usd
CY2023Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
50000000.0 usd
CY2023Q3 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
8700000 usd
CY2023Q3 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
2691300000 usd
CY2023Q3 us-gaap Inventory Real Estate
InventoryRealEstate
22373300000 usd
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2519900000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
187200000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445400000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
2993000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
163500000 usd
CY2023Q3 us-gaap Assets
Assets
32582400000 usd
CY2023Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1246200000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3103800000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
5094500000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9444500000 usd
CY2023Q4 us-gaap Revenues
Revenues
7726000000 usd
CY2023Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
6100000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
5719800000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
835000000.0 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
76300000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1247500000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20000000.0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-153400000 usd
CY2022Q4 us-gaap Revenues
Revenues
7257800000 usd
CY2022Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
27500000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
5291300000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
737000000.0 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37700000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1267200000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19800000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
829100000 usd
CY2023Q4 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2022Q4 us-gaap Inventory Write Down
InventoryWriteDown
4800000 usd
CY2023Q4 dhi Write Offs Recoveries Of Earnest Money Deposits And Pre Acquisition Costs
WriteOffsRecoveriesOfEarnestMoneyDepositsAndPreAcquisitionCosts
6100000 usd
CY2022Q4 dhi Write Offs Recoveries Of Earnest Money Deposits And Pre Acquisition Costs
WriteOffsRecoveriesOfEarnestMoneyDepositsAndPreAcquisitionCosts
22700000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
5290400000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
5094500000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
286400000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
237400000 usd
CY2023Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
42600000 usd
CY2022Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
46200000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
28000000.0 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
28500000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
301000000.0 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
255100000 usd
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2000000000 usd
CY2023Q4 us-gaap Principal Amount Outstanding On Loans Held For Sale Or Securitization
PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization
2000000000 usd
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2500000000 usd
CY2023Q3 us-gaap Principal Amount Outstanding On Loans Held For Sale Or Securitization
PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization
2600000000 usd
CY2023Q4 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
5100000000 usd
CY2022Q4 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
4600000000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
5700000000 usd
CY2022Q4 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
5200000000 usd
CY2023Q4 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
128700000 usd
CY2022Q4 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
79200000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
291800000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
298900000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
CY2023Q4 dhi Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
190700000 usd
CY2023Q3 dhi Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
202000000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14800000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14800000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
947400000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
958700000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
333300000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344200000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2400000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2700000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335700000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
346900000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.79
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.82
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.76
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
CY2023Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3300000 shares
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
398300000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
201600000 usd
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1300000000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
99900000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
512400000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
454300000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
45100000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
39900000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
4500000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1100000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
30200000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
31300000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
531800000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
464000000.0 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
814500000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2023Q3 dhi Construction Defect Portion Of Loss Contingency Accrual
ConstructionDefectPortionOfLossContingencyAccrual
0.97
CY2023Q4 dhi Construction Defect Portion Of Loss Contingency Accrual
ConstructionDefectPortionOfLossContingencyAccrual
0.97
CY2023Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
26400000 usd
CY2022Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
18800000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
729100000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
-4700000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
26900000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
39700000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
7500000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
814500000 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
748500000 usd
CY2023Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
131500000 usd
CY2023Q3 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
165800000 usd
CY2022Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
143600000 usd
CY2023Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
1900000000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
22500000000 usd
CY2023Q4 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
3200000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
253900000 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
1943800000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
1859600000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
16500000 usd
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
153600000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
310600000 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
319600000 usd
CY2023Q4 us-gaap Margin Deposit Assets
MarginDepositAssets
181100000 usd
CY2023Q3 us-gaap Margin Deposit Assets
MarginDepositAssets
0 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
163900000 usd
CY2023Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
167200000 usd
CY2023Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
131500000 usd
CY2023Q3 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
165800000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
100800000 usd
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
93000000.0 usd
CY2023Q4 dhi Contract Asset Insurance Renewals
ContractAssetInsuranceRenewals
97900000 usd
CY2023Q3 dhi Contract Asset Insurance Renewals
ContractAssetInsuranceRenewals
93900000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43300000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46600000 usd
CY2023Q4 us-gaap Servicing Asset
ServicingAsset
18000000.0 usd
CY2023Q3 us-gaap Servicing Asset
ServicingAsset
11100000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
39200000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
80300000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
3127700000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
2993000000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
814500000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
470300000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
531000000.0 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
531800000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
512400000 usd
CY2023Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
363000000.0 usd
CY2023Q3 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
353600000 usd
CY2023Q4 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 usd
CY2023Q3 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
118900000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
122400000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
147100000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
517300000 usd
CY2023Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
233800000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
49500000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
69200000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
44500000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
48100000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
21500000 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
33600000 usd
CY2023Q4 us-gaap Other Derivatives Not Designated As Hedging Instruments Liabilities At Fair Value
OtherDerivativesNotDesignatedAsHedgingInstrumentsLiabilitiesAtFairValue
170600000 usd
CY2023Q3 us-gaap Other Derivatives Not Designated As Hedging Instruments Liabilities At Fair Value
OtherDerivativesNotDesignatedAsHedgingInstrumentsLiabilitiesAtFairValue
15700000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
122000000.0 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
147600000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3227400000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3103800000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
dhi-20231231_lab.xml Edgar Link unprocessable
dhi-20231231_cal.xml Edgar Link unprocessable
dhi-20231231_pre.xml Edgar Link unprocessable
dhi-20231231_def.xml Edgar Link unprocessable
0000882184-24-000014-index-headers.html Edgar Link pending
0000882184-24-000014-index.html Edgar Link pending
0000882184-24-000014.txt Edgar Link pending
0000882184-24-000014-xbrl.zip Edgar Link pending
a12312023exhibit221.htm Edgar Link pending
a12312023exhibit311.htm Edgar Link pending
a12312023exhibit312.htm Edgar Link pending
a12312023exhibit321.htm Edgar Link pending
a12312023exhibit322.htm Edgar Link pending
dhi-20231231.htm Edgar Link pending
dhi-20231231.xsd Edgar Link pending
dhi-20231231_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
dhi-20231231_htm.xml Edgar Link completed
Show.js Edgar Link pending